Elias A. Rahal
Department of Experimental Pathology,
Immunology and Microbiology,
Faculty of Medicine,
Center for Infectious Diseases Research (CIDR),
Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine,
Center for Infectious Diseases Research (CIDR), Faculty of Medicine
American University of Beirut
Elias A. Rahal has not added Biography.
If you are Elias A. Rahal and would like to personalize this page please email our Author Liaison for assistance.
Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice.
International journal of antimicrobial agents Feb, 2011 | Pubmed ID: 21129928
Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of Escherichia coli O157:H7-infected BALB/c mice.
Annals of clinical microbiology and antimicrobials Sep, 2011 | Pubmed ID: 21906403
The impact of prophylactic antiviral agents and statin administration on graft longevity in kidney allograft recipients.
Immunopharmacology and immunotoxicology Oct, 2012 | Pubmed ID: 22292901
Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.
Frontiers in cellular and infection microbiology , 2012 | Pubmed ID: 23162800
Effects of subinhibitory concentrations of antimicrobial agents on Escherichia coli O157:H7 Shiga toxin release and role of the SOS response.
Foodborne pathogens and disease Sep, 2013 | Pubmed ID: 23808851
Effect of rifampicin and gentamicin on Shiga toxin 2 expression level and the SOS response in Escherichia coli O104:H4.
Foodborne pathogens and disease Jan, 2015 | Pubmed ID: 25383748
Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype.
Frontiers in cellular and infection microbiology , 2015 | Pubmed ID: 25853096
Epstein-Barr Virus and Human herpes virus 6 Type A DNA Enhance IL-17 Production in Mice.
Viral immunology Jun, 2015 | Pubmed ID: 25870901
Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice.
Frontiers in microbiology , 2015 | Pubmed ID: 26732740
Epstein-Barr Virus DNA Enhances Diptericin Expression and Increases Hemocyte Numbers in via the Immune Deficiency Pathway.
Frontiers in microbiology , 2018 | Pubmed ID: 29942298
Epstein-Barr virus DNA modulates regulatory T-cell programming in addition to enhancing interleukin-17A production via Toll-like receptor 9.
PloS one , 2018 | Pubmed ID: 29995930
The role of viral infections in the development of autoimmune diseases.
Critical reviews in microbiology Aug, 2019 | Pubmed ID: 31145640
Endosomal Toll-Like Receptors Mediate Enhancement of Interleukin-17A Production Triggered by Epstein-Barr Virus DNA in Mice.
Journal of virology 10, 2019 | Pubmed ID: 31375581
Atorvastatin increases the production of proinflammatory cytokines and decreases the survival of Escherichia coli-infected mice.
Scientific reports 08, 2019 | Pubmed ID: 31406240
Endosomal Toll-Like Receptors (TLRs) mediate enhancement of IL-17A production triggered by Epstein-Barr virus (EBV) DNA in mice.
Journal of infection in developing countries Feb, 2018 | Pubmed ID: 31805001
Triple Immunotherapy Overcomes Immune Evasion by Tumor in a Melanoma Mouse Model.
Frontiers in oncology , 2020 | Pubmed ID: 32596146
as a Model System to Assess the Effect of Epstein-Barr Virus DNA on Inflammatory Gut Diseases.
Frontiers in immunology , 2021 | Pubmed ID: 33828545
Effect of Epstein-Barr Virus DNA on the Incidence and Severity of Arthritis in a Rheumatoid Arthritis Mouse Model.
Frontiers in immunology , 2021 | Pubmed ID: 34040613
Epstein-Barr Virus DNA Exacerbates Colitis Symptoms in a Mouse Model of Inflammatory Bowel Disease.
Viruses 06, 2021 | Pubmed ID: 34210024
IL-17A in COVID-19 Cases: a meta-analysis.
Journal of infection in developing countries 11, 2021 | Pubmed ID: 34898490
Methods for fighting emerging pathogens.
Nature methods 04, 2022 | Pubmed ID: 35396474
Editorial: The microbial modulation of autoimmune processes and proinflammatory pathways.
Frontiers in cellular and infection microbiology , 2022 | Pubmed ID: 35982782
Copyright © 2023 MyJoVE Corporation. All rights reserved